Paper37322012
Primary central nervous system lymphoma.
Ferreri AJM and 10 others. Nat Rev Dis Primers, 2023. Cited by 214 papers, by iCite.
Cite this record
ConductScience Library. Primary central nervous system lymphoma. Papers, record 37322012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37322012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cell Transplantation | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Lymphoma | Major topic |
| Humans | |
| Aged | |
| Combined Modality Therapy | |
| Endothelial Cells | |
| Transplantation, Autologous | |
| Neoplasm Recurrence, Local | |
| Brain |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH |
Source NIH RePORTER
References216
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29713087 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. | Nat Med | 2018 | https://conductscience.org/library/papers/29713087 | PubMed |
| 2 | 14592832 | Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. | Blood | 2004 | https://conductscience.org/library/papers/14592832 | PubMed |
| 3 | 28982883 | Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study. | Anticancer Res | 2017 | https://conductscience.org/library/papers/28982883 | PubMed |
| 4 | 12525518 | Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12525518 | PubMed |
| 5 | 15653703 | High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. | Ann Oncol | 2005 | https://conductscience.org/library/papers/15653703 | PubMed |
| 6 | 24061549 | Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. | Acta Neuropathol | 2013 | https://conductscience.org/library/papers/24061549 | PubMed |
| 7 | 19494841 | Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma. | Leukemia | 2009 | https://conductscience.org/library/papers/19494841 | PubMed |
| 8 | 24105672 | Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. | Cancer | 2013 | https://conductscience.org/library/papers/24105672 | PubMed |
| 9 | 25189415 | The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. | Leukemia | 2015 | https://conductscience.org/library/papers/25189415 | PubMed |
| 10 | 35732829 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732829 | PubMed |
| 11 | 32026432 | Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma. | J Neurooncol | 2020 | https://conductscience.org/library/papers/32026432 | PubMed |
| 12 | 34063335 | Breaching the Blood-Brain Tumor Barrier for Tumor Therapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34063335 | PubMed |
| 13 | 31925841 | Expression of the ghrelin/growth hormone secretagogue receptor axis and its functional role in promoting tumor growth in primary central nervous system lymphomas. | Neuropathology | 2020 | https://conductscience.org/library/papers/31925841 | PubMed |
| 14 | 19767089 | High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. | Lancet | 2009 | https://conductscience.org/library/papers/19767089 | PubMed |
| 15 | 23721553 | Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. | Am J Transplant | 2013 | https://conductscience.org/library/papers/23721553 | PubMed |
| 16 | 26757737 | Genomic characterization of primary central nervous system lymphoma. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/26757737 | PubMed |
| 17 | 31886867 | Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. | J Neuropathol Exp Neurol | 2020 | https://conductscience.org/library/papers/31886867 | PubMed |
| 18 | 15232310 | Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients. | Medicine (Baltimore) | 2004 | https://conductscience.org/library/papers/15232310 | PubMed |
| 19 | 29054815 | Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. | Lancet Haematol | 2017 | https://conductscience.org/library/papers/29054815 | PubMed |
| 20 | 31869415 | Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. | Blood Adv | 2019 | https://conductscience.org/library/papers/31869415 | PubMed |
Cited by166
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983653 | Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42983653 | PubMed |
| 42977864 | Pediatric suprasellar primary CNS lymphoma with cavernous sinus invasion and ischemic stroke: a case report and systematic review. | Childs Nerv Syst | 2026 | https://conductscience.org/library/papers/42977864 | PubMed |
| 42965234 | Anaplastic Large Cell Lymphoma of the Brain Mimicking an Extra-Axial Frontal Tumor: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42965234 | PubMed |
| 42938799 | Vitreoretinal Lymphoma: From Pathobiology to Integrated Diagnosis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938799 | PubMed |
| 42931981 | Bilateral hearing impairment as an unusual symptom of primary central nervous system lymphoma: a presumed central auditory presentation in a young immunocompetent patient. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42931981 | PubMed |
| 42910270 | Efficacy and Safety of an Orelabrutinib-Based Oral Induction Regimen in Central Nervous System Lymphoma: A Real-World Study. | Blood Lymphat Cancer | 2026 | https://conductscience.org/library/papers/42910270 | PubMed |
| 42830763 | IMiD-based monotherapy for maintenance of remission in primary CNS lymphoma: a single-center experience. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42830763 | PubMed |
| 42823715 | Advances in molecular pathobiology of PCNSL - towards clinical implementation of novel diagnostics and therapeutics. | Biomark Res | 2026 | https://conductscience.org/library/papers/42823715 | PubMed |
| 42814177 | Primary central nervous system lymphoma in the molecular era: genomic drivers, liquid biopsy, and targeted therapeutic strategies. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42814177 | PubMed |
| 42811343 | Genetic orchestration of the primary central nervous system lymphoma microenvironment. | Biomark Res | 2026 | https://conductscience.org/library/papers/42811343 | PubMed |
| 42793717 | Spectrum of Neuroimaging Findings in CNS Lymphoproliferative Disorders. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42793717 | PubMed |
| 42741313 | Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42741313 | PubMed |
| 42682662 | Case Report: Rare brainstem involvement in anti-metabotropic glutamate receptor 1 encephalitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42682662 | PubMed |
| 42668694 | Spatial pattern-driven interpretable model and biological correlates in brain glioblastoma-lymphoma differentiation. | iScience | 2026 | https://conductscience.org/library/papers/42668694 | PubMed |
| 42609866 | No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma. | Hemasphere | 2026 | https://conductscience.org/library/papers/42609866 | PubMed |
| 42592300 | Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42592300 | PubMed |
| 42564765 | CNS involvement by EBV-positive extranodal T-cell lymphoma harboring STAT3 Y640F mutation following allogeneic hematopoietic stem cell transplantation: A case report. | Radiol Case Rep | 2026 | https://conductscience.org/library/papers/42564765 | PubMed |
| 42473159 | Case Report: Primary Central Nervous System Lymphoma With "Wine Glass" Sign Presenting as Somnolence and Fatigue. | Am J Case Rep | 2026 | https://conductscience.org/library/papers/42473159 | PubMed |
| 42430569 | Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study. | Hematol Oncol | 2026 | https://conductscience.org/library/papers/42430569 | PubMed |
| 42428147 | MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance. | Front Oncol | 2026 | https://conductscience.org/library/papers/42428147 | PubMed |
Genes85
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37322012
GET https://conductscience.org/api/papers/v1/37322012/references?page=2